Man Group’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $651K | Sell |
43,334
-31,206
| -42% | -$469K | ﹤0.01% | 1528 |
|
|
2025
Q1 | $983K | Sell |
74,540
-82,426
| -53% | -$1.09M | ﹤0.01% | 1378 |
|
|
2024
Q4 | $2.48M | Sell |
156,966
-885,729
| -85% | -$14M | 0.01% | 1120 |
|
|
2024
Q3 | $16.6M | Buy |
1,042,695
+439,820
| +73% | +$6.99M | 0.04% | 473 |
|
|
2024
Q2 | $9.19M | Sell |
602,875
-2,924,940
| -83% | -$44.6M | 0.02% | 698 |
|
|
2024
Q1 | $51.8M | Sell |
3,527,815
-298,150
| -8% | -$4.37M | 0.13% | 153 |
|
|
2023
Q4 | $53.2M | Buy |
+3,825,965
| New | +$53.2M | 0.15% | 151 |
|
|
2023
Q3 | – | Sell |
-777,430
| Closed | -$9.81M | – | 154 |
|
|
2023
Q2 | $9.81M | Buy |
+777,430
| New | +$9.81M | 0.03% | 628 |
|
|
2023
Q1 | – | Sell |
-173,665
| Closed | -$1.8M | – | 1145 |
|
|
2022
Q4 | $1.8M | Sell |
173,665
-31,380
| -15% | -$325K | 0.01% | 1142 |
|
|
2022
Q3 | $2.15M | Buy |
+205,045
| New | +$2.15M | 0.01% | 1039 |
|
|
2022
Q2 | – | Sell |
-231,045
| Closed | -$2.58M | – | 1071 |
|
|
2022
Q1 | $2.58M | Buy |
231,045
+39,500
| +21% | +$440K | 0.01% | 1135 |
|
|
2021
Q4 | $2.51M | Sell |
191,545
-11,500
| -6% | -$150K | 0.01% | 1109 |
|
|
2021
Q3 | $2.65M | Sell |
203,045
-1,500
| -0.7% | -$19.5K | 0.01% | 1084 |
|
|
2021
Q2 | $3.01M | Sell |
204,545
-33,955
| -14% | -$499K | 0.01% | 1092 |
|
|
2021
Q1 | $2.93M | Buy |
238,500
+11,000
| +5% | +$135K | 0.01% | 955 |
|
|
2020
Q4 | $3.24M | Sell |
227,500
-233,000
| -51% | -$3.32M | 0.01% | 1008 |
|
|
2020
Q3 | $6.41M | Sell |
460,500
-271,880
| -37% | -$3.78M | 0.03% | 687 |
|
|
2020
Q2 | $7.77M | Buy |
732,380
+261,500
| +56% | +$2.77M | 0.04% | 460 |
|
|
2020
Q1 | $3.8M | Buy |
+470,880
| New | +$3.8M | 0.02% | 609 |
|
|
2019
Q1 | – | Sell |
-480,500
| Closed | -$3.62M | – | 2033 |
|
|
2018
Q4 | $3.62M | Buy |
+480,500
| New | +$3.62M | 0.02% | 927 |
|